Core Viewpoint - The article highlights the accelerated pace of IPO approvals for technology companies in China, particularly on the Sci-Tech Innovation Board and the Growth Enterprise Market, indicating strong regulatory support for tech innovation [2][4]. Summary by Sections IPO Review Dynamics - The China Securities Regulatory Commission (CSRC) has shown increased efficiency in the IPO review process, with several technology companies achieving registration within the same year they submitted their applications [2][5]. Technology Company IPOs - Notable examples include Mu Xi Co., which received its registration approval in 136 days after submission, and Jianxin Superconducting, which took 181 days [3]. - A total of 8 companies on the "Double Innovation Board" received approvals this year, with an average review time of less than 156 days [4]. Overall Market Trends - As of November 21, 14 IPOs were scheduled for review in November alone, marking a monthly record for the year [5]. - The number of companies scheduled for review has increased significantly from previous quarters, with 32 companies reviewed in Q3 compared to 8 in Q1 [5]. Regulatory Support - The CSRC has emphasized the importance of capital markets in driving technological development, with plans to enhance the inclusivity and adaptability of the capital market system [4][5]. Backlog and Long Wait Times - Despite the acceleration in new applications, there remains a backlog of companies that have been waiting for over 800 days for their IPO reviews, indicating ongoing challenges in the system [6].